Literature DB >> 11279155

Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.

T B Deb1, L Su, L Wong, E Bonvini, A Wells, M David, G R Johnson.   

Abstract

The ErbB family of receptors, which includes the epidermal growth factor receptor (EGFR), ErbB2, ErbB3, and ErbB4, mediate signaling by EGF-like polypeptides. To better understand the role of the EGFR tyrosine kinase, we analyzed signaling by a kinase-inactive EGFR (K721M) in ErbB-devoid 32D cells. K721M alone exhibited no detectable signaling capacity, whereas coexpression of K721M with ErbB2, but not ErbB3 or ErbB4, resulted in EGF-dependent mitogen-activated protein kinase (MAPK) activation. The kinase activity, but not tyrosine phosphorylation, of ErbB2 was required for EGF-induced MAPK activation. The presence of tyrosine phosphorylation sites in K721M was not a requisite for signaling, indicating that transphosphorylation of K721M by ErbB2 was not an essential mechanism of receptor activation. Conversely, the mutated kinase domain of K721M (residues 648-973) and tyrosine phosphorylation of at least one of the receptors were necessary. EGF was found to activate the pro-survival protein kinase Akt in stable cell lines expressing K721M and ErbB2 but, unlike cells expressing wild-type EGFR, was incapable of activating signal transducers and activators of transcription (STAT) or driving cell proliferation. These results demonstrate that EGFR-ErbB2 oligomers are potent activators of MAPK and Akt, and this signaling does not require EGFR kinase activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279155     DOI: 10.1074/jbc.M100928200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.

Authors:  Delphine R Boulbes; Stefan T Arold; Gaurav B Chauhan; Korina V Blachno; Nanfu Deng; Wei-Chao Chang; Quanri Jin; Tzu-Hsuan Huang; Jung-Mao Hsu; Samuel W Brady; Chandra Bartholomeusz; John E Ladbury; Steve Stone; Dihua Yu; Mien-Chie Hung; Francisco J Esteva
Journal:  Mol Oncol       Date:  2014-11-11       Impact factor: 6.603

Review 2.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

3.  Specific epidermal growth factor receptor autophosphorylation sites promote mouse colon epithelial cell chemotaxis and restitution.

Authors:  Toshimitsu Yamaoka; Mark R Frey; Rebecca S Dise; Jessica K Bernard; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-05-26       Impact factor: 4.052

Review 4.  EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.

Authors:  Cristina Zahonero; Pilar Sánchez-Gómez
Journal:  Cell Mol Life Sci       Date:  2014-03-27       Impact factor: 9.261

5.  Epidermal growth factor receptors control competence to interpret leukemia inhibitory factor as an astrocyte inducer in developing cortex.

Authors:  Jane Viti; Angela Feathers; Jennifer Phillips; Laura Lillien
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

6.  Identification and characterization of SSTK, a serine/threonine protein kinase essential for male fertility.

Authors:  Nikolay A Spiridonov; Lily Wong; Patricia M Zerfas; Matthew F Starost; Svetlana D Pack; Cloud P Paweletz; Gibbes R Johnson
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

7.  Generation of functional radial glial cells by embryonic and adult forebrain neural stem cells.

Authors:  Christopher Gregg; Samuel Weiss
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

8.  Autophosphorylation of EGFR at Y954 Facilitated Homodimerization and Enhanced Downstream Signals.

Authors:  Ovia M Thirukkumaran; Malgorzata Kluba; Johan Hofkens; Hideaki Mizuno
Journal:  Biophys J       Date:  2020-10-21       Impact factor: 4.033

9.  Epidermal growth factor activates Na(+/)H(+) exchanger in podocytes through a mechanism that involves Janus kinase and calmodulin.

Authors:  Sonya D Coaxum; Maria N Garnovskaya; Monika Gooz; Aleksander Baldys; John R Raymond
Journal:  Biochim Biophys Acta       Date:  2009-03-31

10.  A Novel Small Molecular Antibody, HER2-Nanobody, Inhibits Tumor Proliferation in HER2-Positive Breast Cancer Cells In Vitro and In Vivo.

Authors:  Yan Yan; Xiao Cheng; Lin Li; Rumeng Zhang; Yong Zhu; Zhengsheng Wu; Keshuo Ding
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.